NAV
₹10.5600
as of 17 Nov 2026
Expense Ratio
3.80%
AUM
₹111 Cr
Lumpsum returns (CAGR)
- 1Y
- —
- 3Y
- —
- 5Y
- —
- Since Inception
- +5.49%
SIP returns (XIRR)
- 1Y
- —
- 3Y
- —
- 5Y
- —
- Since Inception
- +86.51%
Not enough verified history to show honest backtest scenarios (this fund is under 3 years old).
Performance Comparison
Related reading
Thinking about Invesco India Pharma and Healthcare Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
- 1Apollo Hospitals Enterprise Limited9.08%
- 2Divi'S Laboratories Limited8.74%
- 3Max Healthcare Institute Limited8.59%
- 4Sai Life Sciences Limited8.49%
- 5Sun Pharmaceutical Industries Limited8.31%
- 6Manipal Health Enterprises Ltd7.97%
- 7Dr Agarwals Health Care Limited7.93%
- 8Sahajanand Medical Technologies Limited7.31%
- 9Global Health Limited5.96%
- 10Corona Remedies Limited5.76%
What this fund does
Invesco India Pharma and Healthcare Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Invesco India Pharma and Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by Invesco Mutual Fund. The fund has been operational for over 0 years. It manages assets worth ₹111 Cr, reflecting investor confidence in the fund's strategy. The current expense ratio is 3.80%.